Glen Eagle Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.46K | Hold |
19
| – | – | ﹤0.01% | 671 |
|
|
2025
Q1 | $9.21K | Hold |
19
| – | – | ﹤0.01% | 651 |
|
|
2024
Q4 | $7.65K | Hold |
19
| – | – | ﹤0.01% | 691 |
|
|
2024
Q3 | $8.84K | Buy |
19
+4
| +27% | +$1.86K | ﹤0.01% | 680 |
|
|
2024
Q2 | $7.03K | Buy |
+15
| New | +$7.03K | ﹤0.01% | 707 |
|
|
2023
Q1 | – | Sell |
-2
| Closed | -$578 | – | 1217 |
|
|
2022
Q4 | $578 | Buy |
+2
| New | +$578 | ﹤0.01% | 1064 |
|
|
2022
Q1 | – | Sell |
-20
| Closed | -$4.39K | – | 978 |
|
|
2021
Q4 | $4.39K | Hold |
20
| – | – | ﹤0.01% | 722 |
|
|
2021
Q3 | $3.63K | Hold |
20
| – | – | ﹤0.01% | 850 |
|
|
2021
Q2 | $4.03K | Hold |
20
| – | – | ﹤0.01% | 840 |
|
|
2021
Q1 | $4.3K | Hold |
20
| – | – | ﹤0.01% | 790 |
|
|
2020
Q4 | $4.73K | Buy |
+20
| New | +$4.73K | ﹤0.01% | 750 |
|